CAMPAIGN FORESHADOWING — As the shutdown standoff over health care funding drags on, GOP leaders are trying to rope one of California's signature policies into the debate. For weeks, the Republicans’ ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.